Patent 7132523 was granted and assigned to Ortho-McNeil Pharmaceutical on November, 2006 by the United States Patent and Trademark Office.
A novel human nucleic acid and polypeptide, termed PRSS11-L, are disclosed. PRSS11-L, which is observed in tissues throughout the body, can be used in methods of detection, gene therapy, and screening.